Bellicum Pharma (BLCM) Earnings
|
Expand Research on BLCM
| Next EPS Date | 5/8/24 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -92.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/22/24 | Q423 | N/A | -$0.04 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/7/23 | Q323 | N/A | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | N/A | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/20/23 | Q323 | N/A | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/27/23 | Q323 | N/A | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/10/23 | Q223 | N/A | -$0.29 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/28/23 | Q223 | N/A | -$0.29 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/21/23 | Q223 | N/A | -$0.29 | N/A | N/A | N/A | N/A | N/A | N/A |
